Farallon-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
135
Total Value
17935796589
Accession Number
0000908834-25-000177
Form Type
13F-HR
Manager Name
Farallon-Capital-Management
Data Enrichment
87% identified
118 identified17 unidentified

Holdings

135 positions • $17.9B total value
Manager:
Search and click to pin securities to the top
Page 5 of 7
BIODESIX INC
Shares:1.9M
Value:$1.2M
% of Portfolio:0.0% ($1.2M/$17.9B)
MADRIGAL PHARMACEUTICALS, INC.
Shares:3.3K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$17.9B)
140755208
Shares:129.7K
Value:$657.5K
% of Portfolio:0.0% ($657.5K/$17.9B)
Forte Biosciences, Inc.
Shares:70.4K
Value:$546.5K
% of Portfolio:0.0% ($546.5K/$17.9B)
Axsome Therapeutics, Inc.
Shares:4.0K
Value:$466.5K
% of Portfolio:0.0% ($466.5K/$17.9B)
Arcutis Biotherapeutics, Inc.
Shares:26.0K
Value:$406.6K
% of Portfolio:0.0% ($406.6K/$17.9B)
Progyny, Inc.
Shares:18.0K
Value:$402.1K
% of Portfolio:0.0% ($402.1K/$17.9B)
BrightSpring Health Services, Inc.
Shares:22.0K
Value:$398.0K
% of Portfolio:0.0% ($398.0K/$17.9B)
Roivant Sciences Ltd.
Shares:37.0K
Value:$373.3K
% of Portfolio:0.0% ($373.3K/$17.9B)
Krystal Biotech, Inc.
Shares:2.0K
Value:$360.6K
% of Portfolio:0.0% ($360.6K/$17.9B)
SOLENO THERAPEUTICS INC
Shares:5.0K
Value:$357.3K
% of Portfolio:0.0% ($357.3K/$17.9B)
Blueprint Medicines Corp
Shares:4.0K
Value:$354.0K
% of Portfolio:0.0% ($354.0K/$17.9B)
Sage Therapeutics, Inc.
Shares:42.8K
Value:$340.3K
% of Portfolio:0.0% ($340.3K/$17.9B)
MERIT MEDICAL SYSTEMS INC
Shares:3.0K
Value:$317.1K
% of Portfolio:0.0% ($317.1K/$17.9B)
UNITED THERAPEUTICS Corp
Shares:1.0K
Value:$308.3K
% of Portfolio:0.0% ($308.3K/$17.9B)
Twist Bioscience Corp
Shares:7.7K
Value:$300.3K
% of Portfolio:0.0% ($300.3K/$17.9B)
07725L102
Shares:1.1K
Value:$299.4K
% of Portfolio:0.0% ($299.4K/$17.9B)
03073E105
Shares:1.0K
Value:$278.1K
% of Portfolio:0.0% ($278.1K/$17.9B)
Arcellx, Inc.
Shares:4.0K
Value:$262.4K
% of Portfolio:0.0% ($262.4K/$17.9B)
GLAUKOS Corp
Shares:2.6K
Value:$255.9K
% of Portfolio:0.0% ($255.9K/$17.9B)